undamentalytics Newsletter
Sign in

Twist Bioscience Corp revenue

Twist Bioscience Corp's revenue was $377m in fiscal 2025, up 20.3% on the year before. Since fiscal 2017 ($10.8m) it has grown at a compound 55.9% a year. Over the last twelve months it was $432m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Sept 20172018Sept 20182019Sept 20192020Sept 20202021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025LTMJun 2026
Revenue11255490132204245313377432
Growth on the year before—+136.2%+113.9%+65.7%+46.9%+53.8%+20.4%+27.7%+20.3%—
Gross profit−13−7729528490133191224
Gross margin—−26.6%12.8%31.8%39.1%41.4%36.6%42.6%50.7%52.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to September 30, 2025
Products and services
Line of business Revenue Share YoY
Ngs Tools $208M 55.3% ▲ 23.0%
Synthetic Genes $114M 30.2% ▲ 22.6%
Antibody Discovery $23.5M 6.2% ▲ 15.4%
Oligo Pools $20.2M 5.4% ▲ 19.7%
Dna and Biopharma Libraries $11.2M 3.0% ▼ 19.7%
Geography
Region Revenue Share YoY
Americas $226M 59.9% ▲ 16.3%
EMEA $124M 33.0% ▲ 34.2%
Asia Pacific $26.8M 7.1% ▲ 0.9%

From Twist Bioscience Corp's 10-K filed November 17, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Twist Bioscience Corp $432m 19.2% 22.4%
Castle Biosciences Inc $357m 3.2% 28.7%
Veracyte, Inc. $562m 17.3% 19.6%
Fulgent Genetics, Inc. $324m 6.8% 1.8%
Azenta, Inc. $614m 4.9% -0.9%
10x Genomics, Inc. $617m -4.3% 2.8%

Compare with peers

Head to head: CSTL vs TWSTTWST vs VCYTFLGT vs TWST

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Twist Bioscience Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Twist Bioscience Corp.